Macquarie Group LTD Ptc Therapeutics, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$24.15 - $31.95 $30,598 - $40,480	-1,267 Reduced 80.09%	315 $9,000
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $31.3 Million - $50.8 Million	-1,730,710 Reduced 99.91%	1,582 $43,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $4.91 Million - $9.2 Million	-219,161 Reduced 11.23%	1,732,292 $38.8 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $12.5 Million - $18.2 Million	308,303 Added 18.76%	1,951,453 $79.4 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $2.92 Million - $3.74 Million	76,470 Added 4.88%	1,643,150 $79.6 Million
Q4 2022 Feb 21, 2023	BUY	$33.53 - $54.79 $149,610 - $244,472	4,462 Added 0.29%	1,566,680 $59.8 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $5.29 Million - $6.81 Million	-126,516 Reduced 7.49%	1,562,218 $78.5 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $3.48 Million - $6.14 Million	135,806 Added 8.75%	1,688,734 $67.7 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1 Million - $1.34 Million	30,101 Added 1.98%	1,552,928 $57.9 Million
Q4 2021 Feb 11, 2022	SELL	$35.36 - $41.86 $1.72 Million - $2.03 Million	-48,614 Reduced 3.09%	1,522,827 $60.7 Million
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $11.7 Million - $14.1 Million	315,825 Added 25.15%	1,571,441 $58.5 Million
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $4.05 Million - $5.27 Million	106,835 Added 9.3%	1,255,616 $53.1 Million
Q1 2021 May 14, 2021	BUY	$46.8 - $68.92 $4.65 Million - $6.85 Million	99,374 Added 9.47%	1,148,781 $54.4 Million
Q4 2020 Feb 16, 2021	BUY	$47.96 - $67.64 $4.66 Million - $6.58 Million	97,229 Added 10.21%	1,049,407 $64 Million
Q3 2020 Nov 13, 2020	BUY	$45.41 - $57.07 $828,278 - $1.04 Million	18,240 Added 1.95%	952,178 $44.5 Million
Q2 2020 Aug 11, 2020	BUY	$42.56 - $54.98 $5.63 Million - $7.27 Million	132,241 Added 16.5%	933,938 $47.4 Million
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $12.8 Million - $23.5 Million	395,128 Added 97.19%	801,697 $35.8 Million
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $13.1 Million - $20.4 Million	406,569 New	406,569 $19.5 Million
Q3 2018 Nov 15, 2018	SELL	$33.9 - $47.77 $6,780 - $9,554	-200 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $5,140 - $9,576	200 New	200 $7,000
Q1 2018 May 11, 2018	SELL	$17.46 - $32.59 $10,476 - $19,554	-600 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$15.14 - $20.89 $68,130 - $94,005	-4,500 Reduced 88.24%	600 $10,000
Q3 2017 Nov 08, 2017	BUY	$16.81 - $21.61 $85,731 - $110,211	5,100	5,100 $102,000

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$387 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$334 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$329 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$313 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$307 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account